Man Group plc - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 171 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
Man Group plc ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$173,494
+104.1%
44,600
+137.7%
0.00%
Q2 2022$85,000
-24.8%
18,765
+22.9%
0.00%
Q1 2022$113,000
-7.4%
15,266
+31.1%
0.00%
-100.0%
Q1 2021$122,000
-88.9%
11,646
-83.7%
0.00%
-80.0%
Q4 2020$1,103,000
+7.0%
71,273
+0.9%
0.01%
+25.0%
Q3 2020$1,031,000
+171.3%
70,634
+256.7%
0.00%
+300.0%
Q4 2019$380,000
+88.1%
19,800
-5.7%
0.00%0.0%
Q3 2019$202,000
+17.4%
21,000
+14.1%
0.00%0.0%
Q4 2018$172,00018,4000.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,180,700$137,941,00010.27%
Palo Alto Investors LP 4,299,901$82,601,0006.92%
Fairmount Funds Management LLC 562,351$10,803,0006.55%
Avoro Capital Advisors LLC 7,000,000$134,470,0004.54%
Pinz Capital Management, LP 8,820$1,694,0004.44%
Birchview Capital, LP 148,000$2,843,0002.52%
Elk Creek Partners, LLC 699,951$13,446,0002.31%
Parkman Healthcare Partners LLC 215,802$4,146,0001.92%
EAM Global Investors LLC 136,402$2,620,0001.53%
SPHERA FUNDS MANAGEMENT LTD. 550,000$10,566,0001.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders